trending Market Intelligence /marketintelligence/en/news-insights/trending/uKGgZZUQhUAjL-xcBviC4Q2 content esgSubNav
In This List

Peregrine Pharmaceuticals cuts workforce by 20%

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Peregrine Pharmaceuticals cuts workforce by 20%

Peregrine Pharmaceuticals Inc. reduced its workforce by 60 employees, or 20% overall, as part of the company's strategy to reduce costs and achieve profitability.

As part of the job cuts, the company reduced its research and development personnel by 50% to 11 employees, its contract development and manufacturing organization business workforce by 20% to 184 employees, and its selling, general and administrative personnel by 8% to 49 employees.

Peregrine expects the job cuts to result in net cost savings of between $3.7 million and $4.3 million in fiscal 2018, as well as over $7 million in reduced annualized operating expenses beginning in fiscal 2019.